Pharmaceutical Technology's In the Lab eNewsletter, February 2022

February 02, 2022

The multispecific analysis of biologics is a complex task that requires appropriate strategies.

February 02, 2022

Personnel need to be trained in various analytical skill sets for biologic drug substance testing.

February 02, 2022

Toxicology studies are an important and required aspect of drug development that are performed to ensure that drugs are deemed safe prior to patient administration and use in clinical trials.

January 28, 2022

IonSense’s DART-MS technology offers rapid drug analysis without the need for sample preparation.

January 28, 2022

Texcell North America’s new lab facility in Frederick, Md., will expand the CRO’s capabilities in R&D cell culture, viral clearance studies, and viral safety testing.

January 28, 2022

Refeyn’s SamuxMP enables routine quantification of empty/full AAV capsid ratios, even in smaller labs, to set a new standard in AAV characterization

January 28, 2022

PhoreMost has entered into separate collaboration agreements with Polaris Quantum Biotech and NeoCura Bio-Medical Technology to discover and develop novel cancer therapeutics.

January 18, 2022

After a previously announced merger, Protagen Protein Services, BioAnalytix, and GeneWerk have formed a new CRO under the name ProtaGene.

January 14, 2022

Fosun Pharma and Insilico Medicine will collaborate on AI-driven drug discovery and development of product candidates targeting multiple disease targets.

January 13, 2022

Fujifilm Diosynth Biotechnologies' 89,000 square-foot expansion of its BioProcess Innovation Center in Research Triangle Park, N.C., will double its capacity to support process characterization.